Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.


Journal

Accident; analysis and prevention
ISSN: 1879-2057
Titre abrégé: Accid Anal Prev
Pays: England
ID NLM: 1254476

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 29 12 2021
revised: 25 03 2022
accepted: 03 05 2022
pubmed: 1 6 2022
medline: 15 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Cannabis is the second most commonly used impairing substance by drivers, after alcohol. As more countries legalize cannabis, there is concern that cannabis-impaired driving will increase. In many countries, police use roadside devices to test for oral fluid THC (the primary psychotropic component in cannabis) to identify drivers who used cannabis; including in countries with non-zero per se limits for THC in blood. This practice is questioned as previous research demonstrates a poor correlation between oral fluid and blood THC concentrations at the individual level. We conducted a meta-analysis to identify all research that compared oral fluid with blood THC levels. We obtained individual-level data from study authors and analyzed pooled individual-level data to calculate sensitivity and specificity of oral fluid THC (at various cut-off values) to detect blood THC above different concentration limits. Finally, we explored practical implications of using oral fluid THC in an enforcement context. Our review found THC concentrations measured in over 18,000 paired samples of oral fluid and blood. We found a good correlation between the presence of THC in oral fluid and presence of THC in blood (sensitivity = 71.2%, specificity = 97.7%). However oral fluid THC, at commonly used cut-off values, is less sensitive and less specific when used as a biomarker to detect people with blood THC concentrations above commonly used per se limits (such as 5 ng/mL). As such, there will be a large number of "false positive" tests if oral fluid THC testing were used as a biomarker for "illegal" THC concentrations in randomly selected drivers. We argue that the adverse implications of false positive oral fluid THC tests in this context outweigh the possible road safety benefits and we recommend against oral fluid THC screening in randomly selected drivers in countries with non-zero per se limits for blood THC. In contrast, oral fluid THC tests appear to be useful for investigating "high-risk" drivers who come to police attention because of evidence of impairment.

Identifiants

pubmed: 35640367
pii: S0001-4575(22)00130-0
doi: 10.1016/j.aap.2022.106694
pii:
doi:

Substances chimiques

Biomarkers 0
Dronabinol 7J8897W37S

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106694

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

M B Robertson (MB)

University of Ottawa, Canada.

A Li (A)

University of Ottawa, Canada.

Y Yuan (Y)

University of British Columbia, Canada.

A Jiang (A)

University of British Columbia, Canada.

H Gjerde (H)

Oslo University Hospital, Norway.

J A Staples (JA)

University of British Columbia, Canada.

J R Brubacher (JR)

University of British Columbia, Canada. Electronic address: Jeff.brubacher@ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH